Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor
In Vivo · 2025
DOI: 10.21873/invivo.14167 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, 2025. Verfasst von Hirotaka Suto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan hirotaka.suto@hyogo-cc.jp. Hauptthemen laut MEDLINE: Sunitinib, Gastrointestinal Stromal Tumors, Antineoplastic Agents, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan hirotaka.suto@hyogo-cc.jp.
- Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan.
Zitieren
APA
Suto, H., Kawamura, M., Morita, M., Sakai, H., Onoe, T., Ikeuchi, K., & Matsumoto, K. (2025). Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor. In Vivo. https://doi.org/10.21873/invivo.14167
Vancouver
Suto H, Kawamura M, Morita M, Sakai H, Onoe T, Ikeuchi K, et al. Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor. In Vivo. 2025. doi:10.21873/invivo.14167
BibTeX
@article{Suto2025,
author = {Suto, Hirotaka and Kawamura, Miyuki and Morita, Mitsunori and Sakai, Hideki and Onoe, Takuma and Ikeuchi, Kyoko and Matsumoto, Koji},
title = {Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14167}
}
EUVIMED